FOXP3 and cancer: While a large number of markers for Tregs have been proposed, FOXP3 remains the single most widely applied phenotypic credential of regulatory activity in cancer and other studies [96]–[98], despite being transiently expressed in activated human and canine conventional T cells lacking regulatory function [46], [99].